Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue SUPPL. 1, 2006, Pages

  Whetten, Kathryn ^a,b   Reif, S ^a   Ostermann, J ^a   Pence, B W ^a   Swartz, M ^c   Whetten, R ^a   Conover, C ^a   Bouis, S ^a   Thielman, N ^a,c   Eron, J ^d  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS;

EID: 33748655232     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600839330     Document Type: Article

References (40)

1. Angelino, A.F., & Treisman, G.J. (2001). Management of psychiatric disorder in patients infected with Human Immunodeficiency Virus. Clinical Infectious Disease, 33, 847-56.
2. Arnsten, J.H., Demas, P.A., Grant, R.W., Gourevitch, M.N., Farzadegan, H., Howard, A.A., & Schoenbaum, E.E. (2000). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-80.
3. Avants, S.K., Warburton, L.A., Hawkins, K.A., & Margolin, A. (2000). Continuation of high-risk behavior by HIV-positive drug users: treatment implications. Journal of Substance Abuse Treatment, 19, 15-22.
4. Bartlett, J.A. (2002). Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndrome, 29(Suppl 1), S2-10.
5. Batki, S.L. (1990). Drug abuse, psychiatric disorders, and AIDS - Dual and triple diagnosis. Western Journal of Medicine, 152, 547-52.
6. Bouis, S., Scovil, C., Reif, S., & Whetten, K. (2006). An integrated, multidimensional treatment model for individuals living with HIV, mental illness and substance abuse. Under review: Health and Social Work.
7. Chesney, M.A., Ickovics, J.R., & Chambers, D.B. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-66.
8. Conover, C., Ostermann, J., & Whetten, K. (2006). Cost-effectiveness of integrated services delivery for patients in North Carolina living with combined HIV/AIDS, chronic mental illness and substance abuse disorders. Working Paper.
9. DiClemente, C.C., & Prochaska, J.O. (1988). Toward a comprehensive, transtheoretical model of change. In W. Miller, & N. Heather (Eds.), Treating addictive behaviors (pp. 3-24). New York: Plenium Press.
10. Douaihy, A.B., Jou, R.J., Gorske, T., & Salloum, I.M. (2003a). Triple diagnosis: Dual diagnosis and HIV disease, Part 1. AIDS Reader, 13, 331-341.
11. Douaihy, A.B., Jou, R.J., Gorske, T., & Salloum, I.M. (2003b). Triple diagnosis: Dual diagnosis and HIV disease, Part 2. AIDS Reader, 13, 375-382.
12. Drake, R.E., Essock, S.M., Shaner, A., Carey, K.B., Minkoff, K., Kola, L., Lynde, D., Osher, F.C., Clark, R.E., & Rickards, L. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52, 469-76.
13. Fairfield, K.M., Libman, J., Davis, R.B., Eisenberg, D.M., & Phillips, R.S. (1999). Delays in protease inhibitor use in clinical practice. Journal of General Internal Medicine, 14, 395-401.
14. First, M.H., Spitzer, R.L., Gibbon, M., & Williams, J. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders - Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
15. Galvan, F.H., Burnam, M.A., & Bing, E.G. (2003). Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. Journal of Psychoactive Drugs, 35(Supp 1), 153-60.
16. Hafkenscheid, A. (1991). Psychometric evaluation of a standardized and expanded Brief Psychiatric Rating Scale. Acta Psychiatria Scandinavia, 84, 294-300.
17. The HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. (2004). The HIV/AIDS treatment adherence, health outcomes and cost study: conceptual foundations and overview. AIDS Care, 16(Supplement 1), S6-S21.
18. Huber, P.J. (1967). The behavior of maximum likelihood estimates under non-standard conditions. In Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley: University of California Press, 1, 221-233.
19. Kelly, J.A., Murphy, D.A., Bahr, G.R., Koob, J.J., Morgan, M.G., Kalichman, S.C., Stevenson, L.Y., Brasfield, T.L., Bernstein, B.M., & St Lawrence, J.S. (1993). Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with Human Immunodeficiency Virus infection. Health Psychology, 12, 215-19.
20. Leonhard, C., Mulvey, K., Gastfriend, D.R., & Shwartz, M. (2000). The Addiction Severity Index: a field study of internal consistency and validity. Journal of Substance Abuse Treatment, 18, 129-35.
21. McGahan, P.L., Griffith, J.A., Parente, R., & McLellan, A.T. (1986). Addiction Severity Index Composite Scores Manual. Philadephia, Pennsylvania: Treatment Research Institute.
22. McHorney, C.A., Ware, J.E. Jr., Lu, J.F., & Sherbourne, C.D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32, 40-66.
23. McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199-213.
24. Miller, W.R. (1996). Motivational Interviewing: Research, practice and puzzles. Addictive Behaviors, 21, 835-42.
25. Morlan, K.K., & Tan, S.Y. (1998). Comparison of the Brief Psychiatric Rating Scale and the Brief Symptom Inventory. Journal of Clinical Psychology, 54, 885-94.
26. Overall, J.E., & Gorham, D.R. (1962). Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
27. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., Wagener, M.M., & Singh, N. (2002). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
28. Pence, B.W., Gaynes, B.N., Whetten, K., Eron, J.J., Ryder, R.W., & Miller, W.C. (2005). Validation of a brief screening instrument for substance abuse and mental illness in HIV+ patients. Journal of Acquired Immunodeficiency Syndromes, 40, 434-444.
29. Prochaska, J.O., DiClemente, C.C., & Norcross, J.C. (1992). In search of how people change: Applications to addictive behavior. American Psychologist, 47, 1102-14.
30. Sherbourne, C.D., Hays, R.D., Fleishman, J.A., Vitiello, B., Magruder, K.M., Bing, E.G., McCaffrey, D., Burnam, A., Longshore, D., Eggan, F., Bozzette, S.A., & Shapiro, M.F. (2000). Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. American Journal of Psychiatry, 157, 248-54.
31. Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., & Moatii, J.P. (2002). Adherence to Highly Active Antiretroviral Therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Social Science and Medicine, 54, 1481-96.
32. Turner, B.J., Fleishman, J.A., Wenger, N., London, A.S., Burnam, M.A., Shapiro, M.F., Bing, E.G., Stein, M.D., Longshore, D., & Bozzette, S.A. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625-33.
33. Velicer, W.F., Prochaska, J., Fava, J.L., Norman, G.J., & Redding, C.A. (1998). Smoking cessation and stress management: Applications of the Transtheoretical Model. Homeostasis, 3, 216-33.
34. Ware, J.E., Snow, K.K., Kosinski, M., & Gandek, B. (1993). SF-36 Health Survey: Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center.
35. Ware, J.E., & Kosinski, M. (2001). SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, Second Edition. Lincoln, RI: QualityMetric.
36. Whetten, K., Reif, S., Napravnik, S., Swartz, M., Thielman, N., Eron, J., Lowe, K., & Soto, T. (2005a). Substance Abuse and Symptoms of Mental Illness among HIV-Positive Persons in the Southeast. Southern Medical Journal, 98, 9-14.
37. Whetten, K., Reif, S., Swartz, M., Stevens, R., Ostermann, J., Hanisch, L., & Eron, J.J. (2005b). A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care and STDs, 19, 89-99.
38. White, H. (1980). A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrika, 48, 817-830.
39. White, H. (1982). Maximum likelihood estimation of misspecified models. Econometrika, 50, 1-25.
40. Zanis, D.A., McLellan, A.T., Cnaan, R.A., & Randall, M. (1994). Reliability and validity of the Addiction Severity Index with a homeless sample. Journal of Substance Abuse Treatment, 11, 541-548.